Free Trial

Booz Allen Hamilton (BAH) Competitors

Booz Allen Hamilton logo
$102.56 -0.64 (-0.62%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$102.48 -0.08 (-0.08%)
As of 09/5/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAH vs. CCRN, CACI, LDOS, SAIC, CTSH, IT, EPAM, DOX, TDC, and HCKT

Should you be buying Booz Allen Hamilton stock or one of its competitors? The main competitors of Booz Allen Hamilton include Cross Country Healthcare (CCRN), CACI International (CACI), Leidos (LDOS), Science Applications International (SAIC), Cognizant Technology Solutions (CTSH), Gartner (IT), EPAM Systems (EPAM), Amdocs (DOX), Teradata (TDC), and The Hackett Group (HCKT).

Booz Allen Hamilton vs. Its Competitors

Cross Country Healthcare (NASDAQ:CCRN) and Booz Allen Hamilton (NYSE:BAH) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

Cross Country Healthcare has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, Booz Allen Hamilton has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500.

Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.34B0.34-$14.56M-$0.26-54.23
Booz Allen Hamilton$11.96B1.06$935M$8.1412.60

Booz Allen Hamilton has a net margin of 8.70% compared to Cross Country Healthcare's net margin of -0.70%. Booz Allen Hamilton's return on equity of 73.05% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-0.70% 1.72% 1.24%
Booz Allen Hamilton 8.70%73.05%11.61%

In the previous week, Booz Allen Hamilton had 11 more articles in the media than Cross Country Healthcare. MarketBeat recorded 16 mentions for Booz Allen Hamilton and 5 mentions for Cross Country Healthcare. Booz Allen Hamilton's average media sentiment score of 1.65 beat Cross Country Healthcare's score of 1.38 indicating that Booz Allen Hamilton is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cross Country Healthcare
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Booz Allen Hamilton
15 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.9% of Booz Allen Hamilton shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cross Country Healthcare currently has a consensus price target of $17.93, indicating a potential upside of 27.16%. Booz Allen Hamilton has a consensus price target of $134.00, indicating a potential upside of 30.65%. Given Booz Allen Hamilton's stronger consensus rating and higher possible upside, analysts plainly believe Booz Allen Hamilton is more favorable than Cross Country Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Booz Allen Hamilton
2 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.25

Summary

Booz Allen Hamilton beats Cross Country Healthcare on 15 of the 17 factors compared between the two stocks.

Get Booz Allen Hamilton News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAH vs. The Competition

MetricBooz Allen HamiltonConsulting IndustryBusiness SectorNYSE Exchange
Market Cap$12.63B$6.69B$6.61B$21.30B
Dividend Yield2.13%1.71%2.74%3.49%
P/E Ratio12.6023.4927.1529.64
Price / Sales1.062.631,087.3485.04
Price / Cash13.2416.5926.9425.18
Price / Book12.955.416.894.55
Net Income$935M$272.15M$199.16M$999.70M
7 Day Performance-5.81%-0.98%-0.06%0.58%
1 Month Performance-7.42%1.23%9.24%5.67%
1 Year Performance-32.57%-6.83%46.61%18.25%

Booz Allen Hamilton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAH
Booz Allen Hamilton
4.884 of 5 stars
$102.56
-0.6%
$134.00
+30.7%
-32.5%$12.63B$11.96B12.6035,800Positive News
CCRN
Cross Country Healthcare
3.5583 of 5 stars
$13.38
+0.1%
$17.93
+34.0%
+3.8%$438.33M$1.34B-51.468,205Positive News
CACI
CACI International
3.5208 of 5 stars
$479.43
-0.1%
$549.69
+14.7%
+1.7%$10.54B$8.63B21.4525,000
LDOS
Leidos
4.1983 of 5 stars
$180.88
-0.3%
$179.46
-0.8%
+16.9%$23.21B$16.66B17.1048,000Trending News
Analyst Forecast
Insider Trade
SAIC
Science Applications International
3.7911 of 5 stars
$117.70
-0.1%
$125.64
+6.7%
-21.2%$5.52B$7.51B19.8526,000Trending News
Earnings Report
Analyst Forecast
CTSH
Cognizant Technology Solutions
4.8608 of 5 stars
$72.25
+0.7%
$86.07
+19.1%
-5.3%$35.29B$20.49B14.68336,800News Coverage
Positive News
Short Interest ↑
IT
Gartner
4.9159 of 5 stars
$251.07
+1.3%
$369.25
+47.1%
-49.2%$19.02B$6.30B15.4521,044Analyst Forecast
EPAM
EPAM Systems
4.7978 of 5 stars
$176.64
+1.4%
$226.25
+28.1%
-17.3%$9.84B$4.73B25.2061,200Positive News
DOX
Amdocs
4.9311 of 5 stars
$85.57
+1.2%
$105.33
+23.1%
+1.3%$9.66B$5.00B17.3629,058News Coverage
Positive News
TDC
Teradata
3.7114 of 5 stars
$20.95
-0.8%
$26.86
+28.2%
-23.4%$1.98B$1.68B18.547,000News Coverage
Positive News
HCKT
The Hackett Group
4.1272 of 5 stars
$20.82
+0.8%
$29.67
+42.5%
-17.0%$572.76M$313.86M34.701,478News Coverage
Positive News
Analyst Forecast
Short Interest ↑

Related Companies and Tools


This page (NYSE:BAH) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners